Literature DB >> 2160251

Melkersson-Rosenthal syndrome.

M R Orlando1, J S Atkins.   

Abstract

Melkersson-Rosenthal syndrome is a rare condition, classically associated with a triad of facial and/or lip edema, fissured tongue, and relapsing facial palsy. This article offers a review of the literature and presents two cases of Melkersson-Rosenthal syndrome associated with elevated serum levels of angiotensin converting enzyme in two patients of Thai descent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160251     DOI: 10.1001/archotol.1990.01870060086017

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  7 in total

1.  [New diagnostic classification of cheilitis and its clinical diagnostic pathway].

Authors:  Xue-Mei Qiu; Lu Jiang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-04-01

2.  Clinicopathological significance of Melkersson-Rosenthal syndrome.

Authors:  Shruti Bohra; Pratik B Kariya; Seema Dinesh Bargale; Shital Kiran
Journal:  BMJ Case Rep       Date:  2015-07-31

3.  Melkersson-rosenthal syndrome: a case report.

Authors:  Adil Basman; Mustafa Gumusok; Serife Degerli; Mustafa Kaya; Meryem Toraman Alkurt
Journal:  J Istanb Univ Fac Dent       Date:  2017-01-02

Review 4.  Management Strategies of Melkersson-Rosenthal Syndrome: A Review.

Authors:  Sumeet R Dhawan; Arushi G Saini; Pratibha D Singhi
Journal:  Int J Gen Med       Date:  2020-02-26

5.  Melkersson-Rosenthal Syndrome in a 38-Year-Old Female Patient: A Rare Case With Complete Triad.

Authors:  Georges Aoun; Nadia Skandri; Hafiza Ghattas; Carlo Maksoud
Journal:  Cureus       Date:  2022-07-28

6.  Idiopathic orofacial granulomatosis in a young patient: A rare entity.

Authors:  Gurumoorthy Kaarthikeyan; M Arvind; Nd Jayakumar; Mihir Khakar
Journal:  J Oral Maxillofac Pathol       Date:  2012-09

7.  Melkersson-Rosenthal syndrome with partial oculomotor nerve palsy.

Authors:  Mehmet Ufuk Aluclu; Ugur Keklikci; Aslan Guzel; Kaan Unlu; Mehmet Tatli
Journal:  Ann Saudi Med       Date:  2008 Mar-Apr       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.